alexa Burden of Tyrosine Kinase Inhibitor Failure in Patients with Chronic Myeloid Leukemia

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Recommended Conferences

Global Summit On Oncology and Breast Cancer

Vienna, Austria

World Clinical Cancer Research and Diagnosis

Tokyo, Japan

Global Summit on Oncology and Cancer Therapy

New York, USA
Burden of Tyrosine Kinase Inhibitor Failure in Patients with Chronic Myeloid Leukemia

Tyrosine kinase inhibitors (TKIs) have been extremely effective at inducing remissions and slowing down the progression of chronic myeloid leukemia (CML) resulting in a significant reduction in morbidity and mortality.

Kropf P, Barnes G, Tang B, Pathak A, Issa JP (2014) Burden of Tyrosine Kinase Inhibitor Failure in Patients with Chronic Myeloid Leukemia. J Leuk (Los Angel) 3:170.

  • Share this page
  • Facebook
  • Twitter
  • LinkedIn
  • Google+
  • Pinterest
  • Blogger
Top